Autologous Cell Therapy for Female Stress Urinary Incontinence
NCT01008943
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Stress Urinary Incontinence
Interventions
BIOLOGICAL:
Autologous Muscle Derived Cells
Sponsor
Cook MyoSite